2026 Strategic Review: The Germany Export Market

Between 2020 and 2024, export values showed significant growth, peaking in 2023 at over 1.66 trillion. Although 2024 saw a contraction to 1.57 trillion, the overall trend remains higher than the 1.33 trillion recorded in 2020, indicating a resilient recovery and long-term expansion in trade volume over the five-year period.

The export portfolio is led by HSCode 870390 (69.2 billion) and pharmaceuticals (HSCode 300490, 55.6 billion). Automotive and medical sectors dominate the top exports, with vehicles and medicine-related categories occupying four of the top five slots, highlighting a strong specialization in high-value manufacturing and healthcare industries.

The United States is the primary export destination, accounting for 17.66% of total trade. European neighbors, led by the Netherlands (12.07%) and France (10.9%), represent a massive collective market share. China also holds a significant position at 10.93%, demonstrating a balanced distribution between transatlantic, regional European, and Asian markets.

The United Kingdom leads emerging partner growth at 100%, followed closely by Poland (99.89%) and the United States (99.49%). Although absolute export values show minor contractions, these markets maintain dominant growth indices. Switzerland and Spain also demonstrate strong positioning, confirming a strategic focus on high-value European and Transatlantic trade corridors to sustain German export momentum.